Details for New Drug Application (NDA): 015296
✉ Email this page to a colleague
NDA 015296 describes SYNALAR, which is a drug marketed by Medimetriks Pharms and is included in four NDAs. It is available from two suppliers. Additional details are available on the SYNALAR profile page.
The generic ingredient in SYNALAR is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in SYNALAR is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 015296
| Tradename: | SYNALAR |
| Applicant: | Medimetriks Pharms |
| Ingredient: | fluocinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 015296
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 0.01% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes | ||||
Complete Access Available with Subscription
